The Cooper Companies, Inc. (COO) Monthly Stock Report - October 14, 2025

Company Overview

The Cooper Companies, Inc., headquartered in San Ramon, California, is a leading player within the healthcare sector, particularly in the Medical Instruments & Supplies industry. Established in 1958, Cooper has built a robust reputation through its two primary segments: CooperVision and CooperSurgical.

CooperVision specializes in manufacturing contact lenses designed for various vision challenges, improving quality of life for millions of users globally. In parallel, CooperSurgical is focused on family and women's health, providing a range of products that includes fertility devices and medical instruments. With a total revenue of approximately $4.05 billion, The Cooper Companies has established a formidable presence across the Americas, Europe, the Middle East, Africa, and the Asia Pacific.

As a critical player in healthcare technology, The Cooper Companies' strategic initiatives and diverse product range position it favorably within the rapidly evolving healthcare landscape.

52-Week Price Performance Analysis

52-Week Price Performance Chart

The stock of The Cooper Companies, Inc. is currently priced at $69.45. Over the past year, the company's share price has witnessed highs of $109.37 and lows of $61.78, reflecting considerable market volatility. An analysis of the 52-week stock price chart reveals a predominantly bearish trend. The stock has been characterized by lower highs and lower lows, reflecting sustained selling pressure.

Key Technical Insights:

• Resistance Level: The previous high at $110 serves as a crucial resistance point that the stock has struggled to revisit. If the stock can break through this level, it may signal a potential reversal from the current bearish trend.
• Support Level: There appears to be significant support forming around the $69 mark. This level is critical--should it hold, it may serve as a cushion against further declines.
• Momentum Indicators: Currently, the stock trades below its 50-day moving average of $69.50, indicating weak momentum. There has been some consolidation around the $69-$70 range recently, suggesting a potential pause before further directional movement.

In conclusion, traders should carefully monitor these key levels and the ongoing market dynamics, as they may play significant roles in dictating future price movements.

Financial Performance and Metrics

As of the latest reporting, The Cooper Companies has shown solid financial performance, underscored by a 5.7% year-over-year increase in quarterly revenue, bringing it to $1.06 billion. Several financial metrics highlight the company's robust fiscal health: - Total Revenue: Approximately $4,045.7 million. - EBITDA: $1,113.1 million, showcasing strong profitability. - Shares Outstanding: 198,808,921 shares, with 7,687,009 shares sold short, representing about 4.01% of the float of 197,502,746 shares available for trading.

These metrics illustrate The Cooper Companies' sound operational capability combined with a strong market position.

Recent News and Developments

Recent developments have further influenced investor sentiment and market perception of The Cooper Companies: - On September 17, 2025, the company announced a $2 billion share repurchase program, which is expected to buy back up to 15.4% of its outstanding shares. This bold move signals confidence in the company's valuation and a commitment to return value to shareholders. - For the upcoming fourth quarter of 2025, Cooper forecasted earnings per share between $1.10 and $1.14, and a full-year EPS range of $4.08 to $4.12. These predictions point toward steady growth amid shifting market conditions.

Such news has been pivotal, as they showcase The Cooper Companies' proactive measures to bolster shareholder value and maintain robust financial performance despite macroeconomic pressures.

Market Sentiment and Analyst Recommendations

The overall market sentiment for The Cooper Companies remains positive, reflected in the consensus rating of "Moderate Buy." Key analysis points include: - Average Price Target: Analysts set an average price target at $84.75, with a high target of $96.00 and a low target of $64.00. This expected range denotes a significant upside potential from the current share price. - Recent Upgrades: Notably, Needham & Company LLC upgraded the stock to a "Buy" rating with a price objective of $94.00, indicating strong confidence in the company's future market performance.

The recommendation key indicates an overall bullish sentiment from analysts, with a mean recommendation score of approximately 2.11 (where a score closer to 1 indicates a strong buy), reinforcing the attractiveness of the stock for potential investors.

Summary of Opportunities and Risks

While opportunities abound given the strong buy recommendations and significant price targets, risks still linger: - Volatility: The stock has experienced substantial volatility throughout the year, which could deter risk-averse investors. - Market Sentiment Changes: External factors influencing healthcare stocks, such as regulatory changes or economic downturns, must be closely monitored, as these could affect company performance and stock valuation.

In summary, The Cooper Companies, Inc. presents a compelling opportunity within the healthcare sector. With strong financial metrics, an attractive analyst consensus, and proactive measures to enhance shareholder value, investors may find COO stock a promising addition to their portfolios--but they should remain vigilant about market conditions and technical indicators.

This report has been prepared for informational purposes only and does not constitute investment advice. Always conduct your own research before making investment decisions.